Irradiation and decontamination of cannabis flower

TL;DR

• Irradiation doesn't replace good growing/drying practice, it corrects after the fact.
• Gamma rays, e-beam and X-ray are the common methods.
• Terpenes are more sensitive to irradiation than cannabinoids.
• There's no uniform labelling requirement for irradiated cannabis in Switzerland.

How does irradiation work technically?

Ionising radiation damages the DNA of microorganisms (bacteria, mold spores) and prevents their multiplication without significantly heating the flower. Gamma rays (usually cobalt-60) penetrate entire packaging, electron beams act more superficially and faster, X-rays sit in between. The method originally comes from the food and spice industry, where it has been regulated for decades.

Effects on terpenes and the consumer experience

Terpenes are volatile molecules sensitive to heat and oxidation. Higher irradiation doses can measurably lower their concentration and alter smell/taste (Russo 2021 discusses this sensitivity in the context of the 'entourage effect'). Cannabinoids like THC and CBD are chemically more stable and usually only slightly affected. For consumers this means: irradiated batches may be microbiologically safer but sensorially less intense.

Swiss legal situation and practice regarding medical cannabis

Since the amendment of the law in August 2022, doctors in Switzerland have been able to prescribe medical cannabis directly without having to obtain an exceptional licence from the Federal Office of Public Health (BAG). These medical products are subject to strict quality requirements in accordance with the Pharmacopoea Europaea. Since medical flowers are often inhaled by severely ill or immunocompromised individuals, they must have an extremely low microbial count. In Switzerland, irradiation is a recognised method for reliably meeting these microbiological requirements for medical preparations, provided that the corresponding authorisations from Swissmedic have been obtained.

Strict quality controls also apply to the Swiss pilot trials under Article 8b of the Narcotics Act (BetmG), as they are conducted in various cities. Here, irradiation is a subject of controversial debate, as recreational consumers prefer natural products and the focus is strongly on the sensory profile. While in the medical sector sterility to protect patients is often prioritised over preserving the full terpene profile, producers for pilot projects usually try to comply with the limit values through optimised cultivation conditions without subsequent irradiation.

• Medical cannabis is subject to the strict limit values of the European Pharmacopoeia for inhalative use.
• Swissmedic monitors compliance with quality standards in the manufacture and processing of medical cannabis.
• In Swiss pilot projects, attempts are made to minimise the use of irradiation processes through optimised cultivation hygiene.
• The declaration of irradiated products is regulated via monographs in the medical sector, but is inconsistent in the recreational sector.

Microbiological requirements and patient safety

The necessity of microbial reduction arises primarily from the health risks to consumers. Cannabis flowers are natural products on which fungi, yeasts, and bacteria can colonise during cultivation, harvesting, and drying. Moulds of the genus Aspergillus are particularly dangerous, as their spores can penetrate deep into the lungs when inhaled and cause severe infections there. While this is usually harmless for healthy individuals, such contamination can be life-threatening for patients with compromised immune systems.

To minimise these risks, pharmacopoeias define strict limits for the total aerobic microbial count as well as for specific pathogens. If a batch slightly exceeds these limits, irradiation is often the only way to salvage the product and release it to the market. Without this sanitisation, valuable harvests would have to be destroyed, which could lead to supply shortages in medical care. Irradiation thus serves as a safety net for patient safety and economic viability.

• Mould spores such as Aspergillus represent a high health risk for immunocompromised patients.
• Irradiation inactivates the DNA of microorganisms so that they can no longer reproduce.
• Sanitisation prevents the total loss of harvests that slightly exceed microbiological limits.
• The treatment ensures consistent microbiological quality throughout the entire shelf life.

Alternative methods for microbial reduction in comparison

In addition to ionising irradiation, other methods exist to reduce the microbial load, but they have specific disadvantages. Thermal sterilisation in an autoclave using hot steam is unsuitable for cannabis flowers, as heat and moisture destroy the valuable cannabinoids and terpenes and damage the flower structure. Chemical processes such as fumigation with ethylene oxide are strictly prohibited for medicinal products and food in Switzerland and the European Union due to toxicity and potential carcinogenic residues.

Newer physical approaches include treatment with ozone or cold plasma as well as controlled dehumidification. Ozone is a strong oxidising agent that effectively kills microbes, but also reacts with the unsaturated compounds of terpenes and can severely impair the aroma. Cold plasma is still in the testing phase and shows promising approaches for surface sterilisation, but does not achieve the deep penetration of gamma rays. Physical irradiation therefore remains the current gold standard for residue-free microbial reduction.

• Steam sterilisation destroys thermally sensitive active ingredients and alters the physical characteristics of the flowers.
• Chemical fumigants such as ethylene oxide are legally banned due to harmful residues.
• Ozone treatments reduce microbes, but lead to undesirable oxidation processes in the terpenes.
• Cold plasma offers a surface-level alternative, but lacks deep penetration into the flower.

Detection and transparency for consumers

For consumers in Switzerland, it is extremely difficult to identify irradiated cannabis flowers without laboratory analysis. Visually, treated flowers do not differ from untreated ones, as the structure of the trichomes and the colour of the flowers are preserved. Only a significantly weakened or atypical odour profile can be an indicator of irradiation, as volatile monoterpenes are partially degraded by the process. However, reliable certainty is only provided by the manufacturer's official certificate of analysis.

The lack of mandatory labelling on end products is frequently criticised by consumer protection groups and cannabis associations. Since there is no uniform obligation in Switzerland to declare the irradiation method on the packaging of medical cannabis or products from pilot trials, the process often remains invisible to the end user. Critics also argue that irradiation can be used to retrospectively mask poor hygiene conditions during cultivation or harvesting, instead of relying on clean production standards from the very beginning.

• Irradiated flowers cannot be visually distinguished from untreated products.
• An altered or diminished terpene profile can be a sensory indication of treatment.
• Only the official Certificate of Analysis (CoA) provides reliable information about the methods used.
• Critics demand a clear declaration obligation to promote transparency and high cultivation standards.

FAQ